HIV/AIDS Incidence, Treatment Status, and Mortality Statistics in the Republic of Korea, 2023.

OBJECTIVES: In this study, we aim to assess the current status of human immunodeficiency virus (HIV) infection, HIV/acquired immune deficiency syndrome (AIDS) treatment, and AIDS-related mortality to support national strategies for HIV/AIDS prevention and management in the Republic of Korea.

METHODS: Statistics on HIV infection were analyzed using Integrated Disease Management System data, epidemiological surveys, health insurance and medical aid records, and national cause-of-death data.

RESULTS: In 2023, 1,005 new HIV infections were reported, including 749 Koreans (74.5%) and 256 foreigners (25.5%). Among these cases, 903 (89.9%) occurred in males. Individuals in their 30s constituted the largest proportion, accounting for 35.4% (356 people) of newly reported infections. Among those infected, 99.6% (564 people) reported sexual contact as the transmission route. In total, 16,963 people received HIV-related treatment in 2023. Among hospitalized patients, the mean length of stay was 32.6 days-longer than for pneumonia (22.6 days) and tuberculosis (22.1 days). There were 45 AIDS-related deaths in 2023. The number of people living with HIV in 2023 reached 16,459, an increase of 591 from the previous year. The proportion of cases among older adults aged ≥60 years has risen annually, increasing from 16.4% in 2020 to 19.4% in 2023.

CONCLUSIONS: Strategic preparation is necessary to address the growing aging population living with HIV. Accordingly, the Korea Disease Control and Prevention Agency plans to implement strengthened policies under the 2nd National Action Plan on HIV/AIDS Prevention and Control (2024-2028) to reduce new infections, promote early detection, support timely treatment and adherence, protect the right to health, and enhance management capacity.